Ningbo Menovo Stock Hits Day High with 8.41% Surge

Ningbo Menovo Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.41% on March 6, 2026. The stock reached an intraday high of CNY 22.48, showcasing its strong market activity. Over the past year, Ningbo Menovo has outperformed the broader market, generating a remarkable return of 56.90%, compared to the China Shanghai Composite's return of 21.98%. Despite a slight decline of 0.31% over the past week, the company's one-month performance remains positive at 3.91%. Financial metrics indicate a market capitalization of CNY 4,472 million, positioning it within the small-cap segment of the pharmaceuticals and biotechnology industry. The company has a price-to-earnings ratio of 44.00 and a price-to-book ratio of 1.93, reflecting its valuation in the market. Ningbo Menovo's return on equity stands at 4.60%, and it maintains a debt-to-equity ratio of 0.37, suggesting a manageable level of debt. The stock's high dividend yield of 0.24% further adds to its appeal in the current market landscape.